The test, although it can cause claustrophobia from the mask to be performed, is useful to thrive in new means of diagnosing and detecting any type of cancer
On cancer may soon be revealed by a simple one breath testafter the researchers started clinical trial to see if with molecules in the mouth can identify the disease
In tests performed by Research on Cancer UK, breath samples were collected by 1,500 people in the hope of being able to detect the smell of odor Volatile organic compoundss (VOC).
All cells produce VOCs every day, but if it is theirs changes in metabolism with factors like cancer, releasing different model.
If the test is successful, that would mean cancer can be detected quickly before it is expanded, when it is easier to treat and when the chances of survival are greater.
The teacher Rebecca Fitzgerald, the chief investigator at the UK Cancer Research Center in Cambridge, explained that there was an urgent need to develop new tools, such as this breath test, which could help detect and diagnose cancer earlier, giving them Patients have the best chance of surviving your illness.
"Through this clinical trial, we hope to find the samples in the breath necessary to detect cancer before that, is the next key step in the development of this technology," he told Telegraph
Breath biopsy test was developed by Cambridge-based Owlstone Medical biotechnology company and is the first to work on multiple types of cancer, paving the way for a universal breath test that can quickly be administered by a general practitioner.
The trial will begin with suspicious patients esophagus and cancer on the stomach and then it will expand prostate cancer, kidneys, bladder, liver, and pancreas in the coming months.
The trial is recruiting patients for Hospital in Adenbrook, in Cambridge, who were referred by their doctor for suspected of suffering from these specific cancers.
They will receive a breath test before other diagnostic tests. Patients will breathe the test for 10 minutes to collect samples, which will then be processed in the biopsy biathy breath of Owlstone Medical in Cambridge, UK.
Rebecca Coulder, 54 years old from Cambridge, was one of the first to apply for the study.
At the age of 30, he was diagnosed Beret's esophagus, a condition in which the cells that set the esophagus are abnormal, which may be an early warning for cancer.
At present, Ms. Coldrick needs invasive endoscopy to detect the disease every two years, but if the new breath test is successful, she will no longer have to undergo a procedure.
Currently, the percentage of detected cancers is at a late stage. when survival is bad. Methods like this can be key to fighting the disease.